Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress XPEL Q1 2026 Earnings Small EPS Beat Drives Stock Up 37 STC Q1 2026 Earnings EPS Surges 485 Above Estimates Title Insurance Momentum Drives Strong Beat CTAS Q1 2026 Earnings EPS Misses Estimates Stock Holds Steady CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment ESPR Q1 2026 Earnings A BottomLine Miss as Investors Look for Growth Catalysts